Microsure: surgical robotics company

Overview

Microsure is an Eindhoven-based medical robotics company developing high-precision robot-assisted systems for microsurgery. Its MUSA-3 system downscales and stabilizes surgeon hand movements for super-microsurgical procedures on lymphatic ducts, blood vessels, and nerves. CE mark approved May 2026. Raised €38M for clinical studies and FDA clearance pathway.

Verified record

Verified deployments: None on file
Active incidents: None on file

Models (1)

View all models →

Current platform

Microsure MUSA-3

Surgical robotic system by Microsure for microsurgical procedures, offering sub-millimeter precision for operations requiring fine suturing and vessel anastomosis with tremor-free control

surgicalView model →

Microsure on the deployment map

View the global map

Microsure has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

No verified deployments for Microsure on the DEPLOY record yet. Track Microsure to know the moment the first one is verified.

Current leadership (1)

Alex Joseph CEOsecondary-verified

Safety record

No incidents on record for Microsure.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Microsure in third-party press

MUSA-3 CE Mark Approved | Microsure Announces New CEO

May 7, 2026

Peer companies

Brainlab2 models
EndoQuest Robotics2 models
Intuitive Surgical2 models
LEM Surgical2 models
MicroPort MedBot2 models
Neocis2 models

Funding rounds (1)

Other2024-01-01
$42M(reported)

See the full valuations ranking →

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Record createdAug 8, 2026
Added to the verified registry

Full change history →

Common questions

What is Microsure?

Microsure is an Eindhoven-based medical robotics company developing high-precision robot-assisted systems for microsurgery. Its MUSA-3 system downscales and stabilizes surgeon hand movements for super-microsurgical procedures on lymphatic ducts, blood vessels, and nerves. CE mark approved May 2026. Raised €38M for clinical studies and FDA clearance pathway.

What does Microsure make?

Microsure has 1 robot model on the DEPLOY registry: Microsure MUSA-3 (Microsure builds physical robots).

Who competes with Microsure?

On the DEPLOY registry, peer companies to Microsure building in the same form factors include Brainlab, EndoQuest Robotics, Intuitive Surgical, LEM Surgical.

Who is the CEO of Microsure?

Alex Joseph is the ceo of Microsure, per the DEPLOY registry.

Where is Microsure headquartered?

Microsure is headquartered in Eindhoven, Netherlands.

How much funding has Microsure raised?

Microsure has raised approximately $38M in disclosed funding on record in the DEPLOY registry.

Where does Microsure operate robots?

Microsure is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.

Is Microsure a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Microsure ranks in roughly the top 90% of companies tracked by the registry.

Is Microsure safe?

Microsure has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Methodology: Claimed (not independently verified) · no sources on file · last reviewed 2026-08-08

Verification posture

Claimed (not independently verified)

Low confidence

Review state

Stable

Last reviewed 2026-08-08

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Peer companies

Brainlab2 models
EndoQuest Robotics2 models
Intuitive Surgical2 models
LEM Surgical2 models
MicroPort MedBot2 models
Neocis2 models

In the press

Recent coverage mentioning Microsure from third-party publications. Automatically surfaced; not part of the verified registry record.

microsure.nlMay 7, 2026

MUSA-3 CE Mark Approved | Microsure Announces New CEO

CE mark approval for MUSA-3 microsurgical robot; Alex Joseph appointed CEO; company enters clinical phase

↗

Machine-readable surfaces

Markdown mirror: /companies/microsure.md
RSS feed: /companies/microsure/feed.xml
JSON-LD: embedded in this page’s head
REST API: /v1/companies/380919b3-4c0a-4c82-899b-74747251e6c9
Revision history: /companies/microsure/history
Data documentation: /data
Query this programmatically: Deploy MCP

Peer companies

Brainlab2 models
EndoQuest Robotics2 models
Intuitive Surgical2 models
LEM Surgical2 models
MicroPort MedBot2 models
Neocis2 models

Reality vs attention

Microsure draws attention at the 1st percentile but verifies reality at the insufficient-data level among surgical robots.

RealityInsufficient datanot enough verified signal yet

Attention1stpctilemedia + video vs surgical robots

Compared to surgical robots →

Peer rankingTop 90% of Surgical

vs funding peers-19.1 ptsbelow funding-adj. expected

Open the Hype Gap chart →

Analysis

Limited public visibility and press coverage relative to peers.

Signal flags

Funding gap >24mo

Dimension breakdown

Verified signal

Insufficient data

29.4HIGH

Insufficient data

Insufficient data

Insufficient data

Attention (reach, not merit)

Market Presence →

1.2LOW

DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.

DEPLOY Indices — verified vs claimed

Claim Integrity Fleet Reality Operator Repeat All indices

Last computed: Aug 9, 2026

Methodology Intelligence layer